Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Myo19em1flox/Cya
Common Name:
Myo19-flox
Product ID:
S-CKO-12937
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Myo19-flox
Strain ID
CKOCMP-66196-Myo19-B6J-VA
Gene Name
Myo19
Product ID
S-CKO-12937
Gene Alias
1110055A02Rik; Myohd1
Background
C57BL/6JCya
NCBI ID
66196
Modification
Conditional knockout
Chromosome
11
Phenotype
MGI:1913446
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Myo19em1flox/Cya mice (Catalog S-CKO-12937) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000093969
NCBI RefSeq
NM_025414
Target Region
Exon 6
Size of Effective Region
~0.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Myo19, a member of a novel class of myosin, is an actin-based motor that has a crucial role in mitochondrial homeostasis. It is associated with pathways related to mitochondrial dynamics, such as fission and fusion, and is important for maintaining mitochondrial function and cellular processes like cell division. Genetic models, especially knockout models, can be valuable for studying its functions [2,3,7].

In Myo19-deficient HEK293T cells, mitochondria were not properly fragmented during mitosis and were asymmetrically partitioned to daughter cells. Respiratory functions of mitochondria were impaired, ROS generation was enhanced, and cell proliferation, cytokinesis, and cell-matrix adhesion were negatively affected. Myo19 also regulates focal adhesions in interphase, and mitochondrial fusion and mitochondrially associated levels of fission protein Drp1 and adaptor proteins dynactin and TRAK1 at prometaphase [6].

Myo19 knockdown in other cell systems induced mitochondrial elongation, while overexpression induced fragmentation. This fragmentation was blocked by a Myo19 mutation predicted to inhibit ATPase activity and strong actin binding. Myo19-driven fragmentation was blocked by depletion of either the CAAX splice variant of the endoplasmic reticulum-anchored formin INF2 or the mitochondrially localized F-actin nucleator Spire1C, suggesting that Myo19 promotes fission by stabilizing mitochondria-ER contacts [1].

Loss of Myo19 in some studies enhanced the microenvironmental ROS gradient and chemotaxis, increasing tumor metastasis [4]. Also, depletion of Myo19 or disruption of its motor activity led to altered mitochondria membrane potential and decreased oxidative phosphorylation (OXPHOS), as it is critical for maintaining cristae structure by associating with the SAM-MICOS super complex [5].

In conclusion, Myo19 is essential for mitochondrial fission, proper mitochondrial partitioning during cell division, maintaining cristae structure for OXPHOS, and preventing enhanced tumor metastasis by regulating the microenvironmental ROS gradient. The use of Myo19-deficient models has significantly contributed to understanding its role in these biological processes and disease-related conditions, providing insights into potential therapeutic targets for diseases associated with mitochondrial dysfunction and cancer metastasis.

References:
1. Coscia, Stephen M, Thompson, Cameron P, Tang, Qing, Lakadamyali, Melike, Holzbaur, Erika L F. 2023. Myo19 tethers mitochondria to endoplasmic reticulum-associated actin to promote mitochondrial fission. In Journal of cell science, 136, . doi:10.1242/jcs.260612. https://pubmed.ncbi.nlm.nih.gov/36744380/
2. Bocanegra, Jennifer L, Adikes, Rebecca, Quintero, Omar A. . Myosin XIX. In Advances in experimental medicine and biology, 1239, 439-451. doi:10.1007/978-3-030-38062-5_20. https://pubmed.ncbi.nlm.nih.gov/32451871/
3. Shneyer, Boris I, Ušaj, Marko, Henn, Arnon. 2015. Myo19 is an outer mitochondrial membrane motor and effector of starvation-induced filopodia. In Journal of cell science, 129, 543-56. doi:10.1242/jcs.175349. https://pubmed.ncbi.nlm.nih.gov/26659663/
4. Ren, Xiaoyu, Shi, Peng, Su, Jing, Hu, Yiping, Wu, Congying. 2024. Loss of Myo19 increases metastasis by enhancing microenvironmental ROS gradient and chemotaxis. In EMBO reports, 25, 971-990. doi:10.1038/s44319-023-00052-y. https://pubmed.ncbi.nlm.nih.gov/38279020/
5. Shi, Peng, Ren, Xiaoyu, Meng, Jie, Li, Bo, Wu, Congying. 2022. Mechanical instability generated by Myosin 19 contributes to mitochondria cristae architecture and OXPHOS. In Nature communications, 13, 2673. doi:10.1038/s41467-022-30431-3. https://pubmed.ncbi.nlm.nih.gov/35562374/
6. Majstrowicz, Katarzyna, Honnert, Ulrike, Nikolaus, Petra, Hemkemeyer, Sandra A, Bähler, Martin. 2021. Coordination of mitochondrial and cellular dynamics by the actin-based motor Myo19. In Journal of cell science, 134, . doi:10.1242/jcs.255844. https://pubmed.ncbi.nlm.nih.gov/34013964/
7. Quintero, Omar A, DiVito, Melinda M, Adikes, Rebecca C, Feliu, Marianela, Cheney, Richard E. 2009. Human Myo19 is a novel myosin that associates with mitochondria. In Current biology : CB, 19, 2008-13. doi:10.1016/j.cub.2009.10.026. https://pubmed.ncbi.nlm.nih.gov/19932026/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest